Back to Search Start Over

Correction: miR-29c plays a suppressive role in breast cancer by targeting the TIMP3/STAT1/FOXO1 pathway.

Authors :
Li, Wan
Yi, Jie
Zheng, Xiangjin
Liu, Shiwei
Fu, Weiqi
Ren, Liwen
Li, Li
Hoon, Dave S. B.
Wang, Jinhua
Du, Guanhua
Source :
Clinical Epigenetics. 7/29/2022, Vol. 14 Issue 1, p1-3. 3p.
Publication Year :
2022

Abstract

DNMT3B promoted migration, invasion, colony formation and growth in 3D Matrigel of MDA-MB-231 miR-29c cells. Figure S6. miR-29c reduced luciferase activity of wild type 3'UTR of DNMT3B-luciferase reporter, and not the mutant type 3'UTR of DNMT3B reporter in MCF-7 cells. [Extracted from the article]

Details

Language :
English
ISSN :
18687075
Volume :
14
Issue :
1
Database :
Academic Search Index
Journal :
Clinical Epigenetics
Publication Type :
Academic Journal
Accession number :
158276387
Full Text :
https://doi.org/10.1186/s13148-022-01317-4